Laurent Degos


Laurent Degos, Professor of Haematology at the University of Paris, was born on July 9, 1945 in Paris from Robert Degos medical doctor, Professor of Dermatology and Monique Lortat Jacob, third of four children, an older brother Jean Denis Professor of Neurology, Claude François Professor of Neurology and a younger sister Bernadette Flamant. He was married to Françoise Fouchard on 16 December 1971 with whom he had three children Juliette Barbarin, Cecile Petit-Degos, and Vincent Degos and 9 grandchildren. The Degos family is from Mugron with several generations of country medical doctors: Jean Baptiste, Alfred and Louis his grandfather.
He is a corresponding member of the French Academy of sciences.

Biography

Laurent Degos obtained his doctorate of medicine in 1976 and his doctorate of University in 1973 at the Paris Diderot University France. He was a resident of the Paris Hospitals and obtained his Master's degree in "Management of health research" in 1983 at Harvard School of health USA.
Laurent Degos, a close collaborator of Jean Dausset since 1969, succeeded him in 1980 as head of the immunogenetics laboratory. He was elected Councillor for International workshops of Histocompatibility. He discovered genes and alleles of the histocompatibility complex, made innovations in formal genetics and population genetics.
He was Vice-President of the Institut Curie and Vice-President of the Institut Pasteur.
Laurent Degos as a research manager has been elected in several evaluation commissions, Director of the University Institute, International Advisor, President of international congresses. His wisdom and the absence of conflict of interest due to his position in national agencies gave him the opportunity to be called upon in various institutions as an advisor. In addition, he is interested in the new generation, writing science books for children, textbooks for students, co-founder and board member of the MURS,. Having been Director of the Inserm U 93 Unit, Director of the University Institute of Haematology, Director of the Doctoral School of Biology and Biotechnology he is an actor in the current debate on scientific integrity.
Laurent Degos has a broad disciplinary field in medical sciences and studies transverse disciplines. He has collectively taken over the concepts and developments as president of public or private research councils. He currently sits on the boards of directors and committees of SMEs: "2nd opinion", Metafora and Care Insight, e-Sana. He has also demonstrated his ability to obtain interdisciplinary and multidisciplinary research for policy within the framework of the Bioalliance of European Medical Societies and has successfully joined European Member States by co-founding Eunet HTA for the study of comparative efficacy of health products and leading Eunet PAS for patient safety research.
Laurent Degos has experience of scientific advice and political responsibilities at the Council of Europe, DG Sanco and DG RTD. He has demonstrated authority and independence as guest scientific advisor for the preparation of the USA Affordable Care Act on comparative efficacy research, representing France alongside 3 other members from the United Kingdom, Germany and Australia, and as guest member of the nomination committee in China for the CAS institute for translational medicine. He was also a member of the High Level Group on Health at the OECD and President of the Sino-French Foundation for Science and Technology.

Scientific work

Laurent Degos has defined platelet glycoproteins recently used as targets for anticoagulation. His original and anti-dogmatic vision made it possible to discover how to transform a malignant cell into a normal cell, with medical doctors in Shanghai including Wang Zhen Yi and Chen Zhu in the case of the most severe acute leukaemia which is now easily and permanently cured in all "standard" cases with two natural products, a vitamin A derivative and Arsenic, without chemotherapy or bone marrow transplantation, opening a new approach to cancer treatment that has won several international awards, including the General Motors Prize, the most prestigious award for cancer research. He also continued his research in social, economic and human sciences as President of the French High Authority on Health where he headed a college of 8 executive members, 400 high-level collaborators, 3,000 experts, to evaluate health technology, to make recommendations for good practices, certify healthcare establishments, and provide medical and economic advice, after having been President of the Afssaps and President of the French Transplant Establishment .
He is the author of several hundred publications.

Main books

He is the author of many books including :

Scientific and research administration bodies